Collaboration to Accelerate Proteogenomics Cancer Care: The Department of Veterans Affairs, Department of Defense, and the National Cancer Institute's Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Network

Clinical Pharmacology and Therapeutics

Volumn 101, Issue 5, 2017, Pages 619-621

  Fiore, L D ^a   Rodriguez, H ^b   Shriver, C D ^c,d  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d Division of Military Epidemiology and Population Sciences John P Murtha Cancer Center Walter Reed Bethesda   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RESEARCH; CANCER THERAPY; GOVERNMENT; HUMAN; MALIGNANT NEOPLASM; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; PROTEOGENOMICS; VETERAN; DRUG DELIVERY SYSTEM; ONCOLOGY; UNITED STATES;

DRUG DELIVERY SYSTEMS; HUMANS; MEDICAL ONCOLOGY; NATIONAL CANCER INSTITUTE (U.S.); PROTEOGENOMICS; UNITED STATES; UNITED STATES DEPARTMENT OF DEFENSE; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 85018486836     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.658     Document Type: Article

References (5)

1. Ellis, M.J. et al. and the Clinical Proteomic Tumor Analysis Consortium (CPTAC). Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. Cancer Discov. 3, 1108–1112 (2013).
2. Zhang, B. et al. and the NCI CPTAC Investigators. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382–387 (2014).
3. Zhang, H. et al. and the CPTAC investigators. Integrated proteogenomic characterization of human high grade serous ovarian cancer. Cell 166, 755–765 (2016).
4. Mertins, P. et al. and the NCI CPTAC. Proteogenomics connects somatic mutations to signaling in breast cancer. Nature 534, 55–62 (2016).
5. Fiore, L.D. et al. The VA Point-of-Care Precision Oncology Program: balancing access with rapid learning in molecular cancer medicine. Biomark. Cancer 8, 9–16 (2016).